Matrix Metalloproteinase-Responsive Delivery of PEGylated Fibroblast Growth Factor 2
- 21 November 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Biomaterials Science & Engineering
- Vol. 10 (1) , 156-165
Abstract
Attachment of polyethylene glycol (PEG) chains is a common, well-studied, and Food and Drug Administration-approved method to address the pharmacokinetic challenges of therapeutic proteins. Occasionally, PEGylation impairs the activity of pharmacodynamics (PD). To overcome this problem, disease-relevant cleavable linkers between the polymer and the therapeutic protein can unleash full PD by de-PEGylating the protein at its target site. In this study, we engineered a matrix metalloproteinase (MMP)-responsive fibroblast growth factor 2 (FGF-2) mutant that was site-specifically extended with a PEG polymer chain. Using bioinspired strategies, the bioconjugate was designed to release the native protein at the desired structure/environment with preservation of the proliferative capacity in vitro on NIH3T3 cells. In vivo, hepatic exposure was diminished but not its renal distribution over time compared to unconjugated FGF-2. By releasing the growth factor from the PEG polymer in response to MMP cleavage, restored FGF-2 may enter hard-to-reach tissues and activate cell surface receptors or nuclear targets.Keywords
Funding Information
- Bundesministerium f?r Bildung und Forschung (16GW0334K)
- Deutsche Forschungsgemeinschaft (TRR225 B06)
This publication has 59 references indexed in Scilit:
- Molecular Insight into the Steric Shielding Effect of PEG on the Conjugated Staphylokinase: Biochemical Characterization and Molecular Dynamics SimulationPLOS ONE, 2013
- The Effect of Cholesterol Domains on PEGylated Liposomal Gene Delivery In VitroTherapeutic Delivery, 2011
- Effect of Cholesterol Nanodomains on the Targeting of Lipid-Based Gene Delivery in Cultured CellsMolecular Pharmaceutics, 2010
- Fibroblast Growth Factors: Biology, Function, and Application for Tissue RegenerationJournal of Tissue Engineering, 2010
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- Jalview Version 2—a multiple sequence alignment editor and analysis workbenchBioinformatics, 2009
- High molecular weight FGF2: the biology of a nuclear growth factorCellular and Molecular Life Sciences, 2008
- Nuclear and Nucleolar Localization of 18-kDa Fibroblast Growth Factor-2 Is Controlled by C-terminal SignalsJournal of Biological Chemistry, 2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Fiblast (Trafermin) in Acute Stroke: Results of the European-Australian Phase II/III Safety and Efficacy TrialCerebrovascular Diseases, 2002